Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126292761 | 12629276 | 1 | I | 20130705 | 20160808 | 20160808 | EXP | US-RANBAXY-2013US-71203 | RANBAXY | STRUNK AD, MAYER SD. RESISTANT HYPERTENSION IN THE ELDERLY: OPTIMIZING OUTCOMES WHILE AVOIDING ADVERSE EFFECTS. CONSULT PHARM. 2013;MAY;28(5):307-12 | 89.00 | YR | F | Y | 0.00000 | 20160808 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126292761 | 12629276 | 1 | SS | DOXAZOSIN | DOXAZOSINDOXAZOSIN MESYLATE | 1 | Oral | 8 MG, DAILY | Y | 0 | 8 | MG | |||||||
| 126292761 | 12629276 | 2 | SS | Fosinopril | FOSINOPRIL | 1 | Oral | 40 MG, DAILY | 0 | 40 | MG | ||||||||
| 126292761 | 12629276 | 3 | PS | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Oral | 25 MG, BID | Y | 89424 | 25 | MG | Q12H | ||||||
| 126292761 | 12629276 | 4 | SS | HYDROCHLOROTHIAZIDE/OLMESARTAN MEDOXOMIL | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | Oral | 25/40 MG, DAILY | Y | 0 | |||||||||
| 126292761 | 12629276 | 5 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 10 MG, DAILY | 0 | 10 | MG | ||||||||
| 126292761 | 12629276 | 6 | C | Atorvastatin | ATORVASTATIN | 1 | Oral | 20 MG, DAILY | U | 0 | 20 | MG | |||||||
| 126292761 | 12629276 | 7 | C | GLIPIZIDE. | GLIPIZIDE | 1 | Oral | 10 MG, DAILY | U | 0 | 10 | MG | |||||||
| 126292761 | 12629276 | 8 | C | METOPROLOL SUCCINATE. | METOPROLOL SUCCINATE | 1 | Oral | 150 MG, DAILY | 0 | 150 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126292761 | 12629276 | 1 | Hypertension |
| 126292761 | 12629276 | 2 | Hypertension |
| 126292761 | 12629276 | 3 | Hypertension |
| 126292761 | 12629276 | 4 | Hypertension |
| 126292761 | 12629276 | 5 | Hypertension |
| 126292761 | 12629276 | 6 | Product used for unknown indication |
| 126292761 | 12629276 | 7 | Product used for unknown indication |
| 126292761 | 12629276 | 8 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126292761 | 12629276 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126292761 | 12629276 | Hyperkalaemia | |
| 126292761 | 12629276 | Multiple drug therapy | |
| 126292761 | 12629276 | Orthostatic hypotension | |
| 126292761 | 12629276 | Renal failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126292761 | 12629276 | 1 | 20080616 | 0 | ||
| 126292761 | 12629276 | 2 | 20060726 | 0 | ||
| 126292761 | 12629276 | 3 | 20081015 | 0 | ||
| 126292761 | 12629276 | 4 | 20090204 | 0 | ||
| 126292761 | 12629276 | 5 | 20060830 | 0 | ||
| 126292761 | 12629276 | 6 | 20050504 | 0 | ||
| 126292761 | 12629276 | 7 | 20070117 | 0 | ||
| 126292761 | 12629276 | 8 | 20080227 | 0 |